CD274 and neoplasm: The remodeling of the suppressive immune microenvironment of tumor was eventually achieved owing to the natural characteristics of M1Exos, as well as the anti‐PD‐L1 antibody expressed on engineered M1Exos for the immune checkpoint blockade.